NEW AND nonofficial remedies.
D003517:Cyclopentanes; D003872:Dermatitis; D003877:Dermatitis, Contact / Q000628:therapy*; D006801:Humans; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D012825:Silicon / Q000627:therapeutic use*; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D013566:Sympathomimetics
D003517:Cyclopentanes; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D013424:Sulfanilamides; D013449:Sulfonamides; D013566:Sympathomimetics; D000077145:Sulfanilamide; D012825:Silicon
CYCLOPENTANES; DERMATITIS, CONTACT/therapy; HYPNOTICS AND SEDATIVES; PARASYMPATHOLYTICS; SILICON/therapeutic use; SULFONAMIDES; SYMPATHOMIMETICS/effects